Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2008-08-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.taap.2008.03.025PMID 18495193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced liver injury

  2019cited by this paper
• Proteomics profiling of hepatic mitochondria in heterozygous Sod2+/− mice, an animal model of discreet mitochondrial oxidative stress

  2008cited by this paper
• Development of Animal Models of Drug-Induced Mitochondrial Toxicity

  2008cited by this paper
• The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes.

  2008cited by this paper
• Troglitazone hepatotoxicity: are we getting closer to understanding idiosyncratic liver injury?

  2007cited by this paper
• Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration.

  2007cited by this paper
• Pharmacokinetic study of intraperitoneally administered troglitazone in mice using ultra-performance liquid chromatography/tandem mass spectrometry.

  2007cited by this paper
• Drug-Induced Liver Injury

  2007cited by this paper
• Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells

  2007cited by this paper
• Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?

  2007cited by this paper
• Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.

  2007cited by this paper
• Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.

  2006cited by this paper
• Uncoupling protein 1 affects the yeast mitoproteome and oxygen free radical production.

  2006cited by this paper
• Idiosyncratic drug hepatotoxicity

  2005cited by this paper
• High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein.

  2005cited by this paper
• Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells.

  2005cited by this paper
• Troglitazone and liver injury: In search of answers

  2005cited by this paper
• Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.

  2004cited by this paper
• Gene expression profiling of rat livers reveals indicators of potential adverse effects.

  2004cited by this paper
• Chaperone proteins involved in troglitazone-induced toxicity in human hepatoma cell lines.

  2004cited by this paper
• Mechanisms of troglitazone hepatotoxicity.

  2003cited by this paper
• Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.

  2003influential reference
• Selective degradation of oxidatively modified protein substrates by the proteasome.

  2003cited by this paper
• The Voltage-dependent Anion Channel Is the Target for a New Class of Inhibitors of the Mitochondrial Permeability Transition Pore*

  2003cited by this paper
• Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.

  2003cited by this paper
• Carbonyl modified proteins in cellular regulation, aging, and disease.

  2002cited by this paper
• Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism

  2002cited by this paper
• Genomics and proteomics analysis of acetaminophen toxicity in mouse liver.

  2002cited by this paper
• Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

  2001cited by this paper
• Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

  2001cited by this paper
• The mitochondrial antioxidant defence system and its response to oxidative stress

  2001cited by this paper
• Modulation of Mitochondrial Function by Hydrogen Peroxide*

  2001cited by this paper
• Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

  2001cited by this paper
• Purification of Saccharomcyes cerevisiae mitochondria devoid of microsomal and cytosolic contaminations.

  2000influential reference
• Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.

  2000cited by this paper
• Peroxynitrite Formation and Decreased Catalase Activity in Autoimmune MRL-lpr/lpr Mice

  2000cited by this paper
• Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.

  1999cited by this paper
• Clinical Pharmacokinetics of Troglitazone

  1999cited by this paper
• Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore.

  1998cited by this paper
• Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

  1996cited by this paper
• Troglitazone Inhibits Fatty Acid Oxidation and Esterification, and Gluconeogenesis in Isolated Hepatocytes from Starved Rats

  1996cited by this paper
• The valine catabolic pathway in human liver: Effect of cirrhosis on enzyme activities

  1996cited by this paper

• Rapid and slow thawing of Takifugu rubripes fillets: TMT-labeled proteomics analysis, biochemical and morphological comparison.

  2025cites this paper
• Deep Learning Prediction of Drug-Induced Liver Toxicity by Manifold Embedding of Quantum Information of Drug Molecules

  2024cites this paper
• Risk Assessment for Hepatobiliary Toxicity Liabilities in Drug Development

  2023cites this paper
• Mitochondrial stress response in drug-induced liver injury

  2021cites this paper
• Models of Idiosyncratic Drug-Induced Liver Injury.

  2020cites this paper
• A Combined N-terminomics and Shotgun Proteomics Approach to Investigate the Responses of Human Cells to Rapamycin and Zinc at the Mitochondrial Level*

  2019cites this paper
• Long-term Engineered Cultures of Primary Mouse Hepatocytes for Strain and Species Comparison Studies During Drug Development.

  2019cites this paper
• Toward Mitochondrial Medicine: Challenges in Rodent Modeling of Human Mitochondrial Dysfunction

  2018cites this paper
• Drug-induced liver injury: recent advances in diagnosis and risk assessment

  2017cites this paper
• Oxidative Stress in Acute Liver Failure

  2015cites this paper
• Deletion of GSTA4-4 results in increased mitochondrial post-translational modification of proteins by reactive aldehydes following chronic ethanol consumption in mice

  2015cites this paper
• Establishment of "in vitro" and "in vivo" models with underlying mitochondrial dysfunction for testing idiosyncratic drug toxicity

  2015cites this paper
• Proteomic characteristics of human sperm cryopreservation

  2014cites this paper
• Mitochondria in metabolic disease: Getting clues from proteomic studies

  2014influential citation
• The Zebrafish Model in Toxicology

  2014cites this paper
• Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.

  2014cites this paper
• The role of mitochondrial aconitate (ACO2) in human sperm motility

  2014cites this paper
• Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging

  2013cites this paper
• Mechanisms of drug-induced liver injury.

  2013cites this paper
• Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone

  2013cites this paper
• The Role of Anesthetic Drugs in Liver Apoptosis

  2013cites this paper
• Utilization of Reverse Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury

  2013cites this paper
• Computational Toxicology Experience and Applications for Risk Assessment in the Pharmaceutical Industry

  2013cites this paper
• Animal models of idiosyncratic drug reactions.

  2012cites this paper
• Current Challenges and Controversies in Drug-Induced Liver Injury

  2012cites this paper
• Mitochondrial bioenergetics and drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA single nucleotide polymorphisms.

  2012cites this paper
• Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development

  2012cites this paper
• Idiosyncratic Drug Reactions

  2012cites this paper
• Proteomics Signature Profiling (PSP): A Novel Contextualization Approach for Cancer Proteomics

  2012cites this paper
• Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug‐Induced Liver and General Organ Toxicity

  2012cites this paper
• Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.

  2011cites this paper
• Pleiotropic Effects of Glitazones: A Double Edge Sword?

  2011cites this paper
• The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity.

  2011cites this paper
• Mechanisms of drug toxicity and relevance to pharmaceutical development.

  2011cites this paper
• Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes

  2011cites this paper
• Animal models of idiosyncratic drug-induced liver injury—Current status

  2011cites this paper
• Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors

  2010cites this paper
• Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver

  2010cites this paper
• 8. Hepatic Toxicity

  2010cites this paper
• Antioxidant Defense Mechanisms

  2010cites this paper
• Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction.

  2010cites this paper
• Mitochondrial GSH and Thioredoxin-2 : Parallel , Non-Redundant Signaling Systems

  2010cites this paper
• Cell‐bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells

  2010cites this paper
• Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

  2010cites this paper
• Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity.

  2009cites this paper
• Mechanism-based bioanalysis and biomarkers for hepatic chemical stress

  2009cites this paper
• The Sod2 mutant mouse as a model for oxidative stress: a functional proteomics perspective.

  2009cites this paper
• Immune-mediated adverse drug reactions.

  2009cites this paper
• Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress.

  2009cites this paper
• Drug-induced liver injury: what was new in 2008?

  2009cites this paper
• The heterozygous Sod2(+/-) mouse: modeling the mitochondrial role in drug toxicity.

  2008cites this paper